Drugs / Vi-PS Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02324751 Comparator | Sep 2015 → Dec 2017 | typhoid fever | University of Oxford | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vi-PS Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02324751 ↗ |
| Modality | Vaccine | “plain-polysaccharide-based vaccine, ViPS” PMID 37402153 ↗ Aug 2023 |